Yes on suit ça de près aussi 😁
20.05.2025 20:08 — 👍 1 🔁 0 💬 0 📌 0@franckdrtourte.bsky.social
PhD in virology Associate professeur in @UVE lab (Marseille, France). Holder of the new chair: Antiviral strategies for emergence in the south @IRD Head of the PCVMT platform ( sub-entity of MaSC) dedicated to antiviral screening with replicating viruses.
Yes on suit ça de près aussi 😁
20.05.2025 20:08 — 👍 1 🔁 0 💬 0 📌 0While not a replacement for standard antiviral screening, this 3D model offers valuable insights into viral replication, pathogenicity, and host-pathogen interactions.
12.05.2025 11:52 — 👍 1 🔁 0 💬 0 📌 0Our research findings:
RVFV and PIRV replicated in the liver spheroids; AHFV and YFV did not.
Broad-spectrum antivirals (favipiravir, nitazoxanide, ribavirin, galidesivir) showed activity, though higher doses were often needed versus traditional 2D models.
Haemorrhagic fever viruses remain a major global health threat—highly lethal, with limited therapeutic options. In our recent study, we explored a 3D human liver spheroid model to evaluate its potential for antiviral assessment against 4 BSL-3 viruses: AHFV, YFV, PIRV, RVFV.
12.05.2025 11:52 — 👍 0 🔁 0 💬 1 📌 0Just published in Antiviral research!
3D Liver Spheroids in the Fight Against Haemorrhagic Fever Viruses
t.co/FuxQ76acrg
@ird-fr.bsky.social @univ-amu.fr @insermpacacorse.bsky.social
On a des antiviraux efficaces: paxlovid ( Nirmatrelvir) et xocova ( ensitrelvir) on sait comment faire un vaccin ou des anticorps thérapeutiques rapidement.
On est entouré de virus à la capacité zoonotique et celui là se rajoute juste à la longue liste mais tkt a l UVE on est là pour ça 😉
Oui c’est uniquement l’entrée mais d’autre facteurs rentrent en ligne de compte pour un changement d’hôte et une zoonose( par exemple la capacité du virus à échapper à la réponse immune). De plus avec le recul un coronavirus est moins inquiétant que d’autres familles virales 1/2
24.02.2025 13:53 — 👍 1 🔁 0 💬 1 📌 0Moreover, pharmacokinetic modeling suggests promising druggability for these compounds.
These results position OM1260 and HR-568 as strong candidates for further development, potentially paving the way for the first curative treatments for enteroviral infections.
Docking studies provided insights into their structure-activity relationships, while time-of-drug addition assays revealed that these inhibitors act early in the viral replication cycle.
14.02.2025 17:21 — 👍 1 🔁 0 💬 1 📌 0This led to the discovery of two promising broad-spectrum inhibitors, OM1260 and HR-568.
Both inhibitors show micromolar activity against multiple enterovirus types (EV-A71, E30, and CVA24), with EC50 values ranging from 0.4 μM to 4.38 μM, depending on the virus strain and cell line.
Our consortium has made an exciting step forward in the fight against these viruses. After developing initial EV-A71 inhibitors, we optimized their structure through iterative chemical modifications to enhance their activity and broaden their spectrum.
14.02.2025 17:21 — 👍 1 🔁 0 💬 1 📌 0Despite their significant impact, there are currently no commercial curative treatments available.
14.02.2025 17:21 — 👍 1 🔁 0 💬 1 📌 0🔬 New Research Breakthrough: Broad-Spectrum Inhibitors for Enteroviruses🦠Enteroviruses (EV) are a diverse group of viruses that can cause a range of illnesses, from mild fever to severe neurological complications.
14.02.2025 17:20 — 👍 2 🔁 2 💬 1 📌 0Read more about our findings in the preprint! 📖
www.biorxiv.org/content/10.1...
Our research underscores the growing importance of advanced 3D models in virology and drug development. This tool could help accelerate the identification of new therapies for HFVs and improve our understanding of their mechanisms.
30.01.2025 07:48 — 👍 0 🔁 0 💬 1 📌 0While this model offers valuable insights, it’s not a replacement for standard selection steps in antiviral drug development but could play a key role in understanding viral pathogenicity and host-pathogen interactions.
30.01.2025 07:47 — 👍 0 🔁 0 💬 1 📌 0Key findings :
RVFV and PIRV were able to replicate in the spheroids, while the orthoflaviviruses did not show replication.
Antiviral compounds like favipiravir, nitazoxanide, ribavirin, and galidesivir demonstrated activity, though higher doses were required in 3D models compared to 2D cultures.
Our latest study explores the use of a 96-well liver spheroid model composed of human primary cells to assess the antiviral activity of key compounds against four BSL-3 HFVs: Alkhumra haemorrhagic fever virus (AHFV), yellow fever virus (YFV), Pirital virus (PIRV), and Rift Valley fever virus (RVFV).
30.01.2025 07:46 — 👍 0 🔁 0 💬 1 📌 0🚨 New Insights on Hemorrhagic Fever Viruses & 3D Cell Culture Models 🦠
In the ongoing battle against hemorrhagic fever viruses (HFVs), the development of effective antiviral strategies remains a critical challenge.
From Rogue virologist
09.01.2025 19:47 — 👍 6 🔁 0 💬 0 📌 0www.nature.com/articles/s41...
The main paper of my PhD thesis
Due to the words limitation i will make it short but thanks to @franckdrtourte.bsky.social , Dr. Suzanne Kaptein, @neytsjohan.bsky.social, Christian Alfano, Carla Gomes da Silva, Ivan Gladwyn-ng, Emily Slowikowski and Prof Marques
🤚please
20.11.2024 16:53 — 👍 0 🔁 0 💬 0 📌 0Merci
14.11.2024 15:03 — 👍 0 🔁 0 💬 0 📌 0👋🏻
14.11.2024 14:06 — 👍 0 🔁 0 💬 1 📌 0👋🏻
13.11.2024 13:56 — 👍 1 🔁 0 💬 0 📌 0C’est énorme! Faut faire une grosse fiesta!
05.11.2024 21:49 — 👍 1 🔁 0 💬 0 📌 0C’est super cool de pouvoir tracer son histoire aussi loin!
05.11.2024 21:09 — 👍 2 🔁 0 💬 0 📌 0Vous avez toujours été en Suisse ou vous avez bougé depuis ces 600 dernières années?
05.11.2024 21:05 — 👍 0 🔁 0 💬 0 📌 0« Pas sérieux » c’est gentiment dit j’aurais été moins poli 😉
31.10.2024 21:47 — 👍 0 🔁 0 💬 0 📌 0